(NASDAQ: GEVO) Gevo's forecast annual revenue growth rate of 73.38% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of -0.51%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.95%.
Gevo's revenue in 2024 is $17,130,000.On average, 3 Wall Street analysts forecast GEVO's revenue for 2024 to be $4,352,824,043, with the lowest GEVO revenue forecast at $3,942,724,047, and the highest GEVO revenue forecast at $4,724,654,340. On average, 3 Wall Street analysts forecast GEVO's revenue for 2025 to be $6,780,587,676, with the lowest GEVO revenue forecast at $5,669,585,208, and the highest GEVO revenue forecast at $7,994,115,143.
In 2026, GEVO is forecast to generate $23,465,704,478 in revenue, with the lowest revenue forecast at $5,669,585,208 and the highest revenue forecast at $50,752,236,920.